Steven Feigenberg, MD, offers a profile of the benefits and advantages of stereotactic body radiation therapy (SBRT) for patients with lung cancer, and reviews the efficacy and safety outcomes and the imaging and conformational benefits of SBRT, as well as the evolving promise of proton therapy.
Recent Links:
Proton Radiotherapy for Recurrent Cancers
Dr Feigenberg’s Profile
Published
February 13, 2018
Created by
BROADCASTMED